Hyperhomocysteinemia: Marker of systemic atherosclerosis in peripheral arterial disease

International Angiology

Volumn 23, Issue 1, 2004, Pages 35-40

  Taute, Bettina Maria ^a   Taute, R ^a   Heins, S ^a   Behrmann, C ^a   Podhaisky, H ^a  

^a MARTIN LUTHER UNIVERSITY HALLE WITTENBERG   (Germany)

Author keywords

Atherosclerosis; Carotid artery diseases; Coronary stenosis; Homocysteine, blood; Peripheral vascular diseases; Renal artery obstruction

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ANKLE PRESSURE; ARTERIAL PRESSURE; ARTERY DISEASE; ARTICLE; ATHEROSCLEROSIS; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CEREBROVASCULAR DISEASE; COMORBIDITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIET RESTRICTION; DISEASE ASSOCIATION; DISEASE MARKER; DOPPLER ECHOGRAPHY; FEMALE; HUMAN; HYPERHOMOCYSTEINEMIA; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORBIDITY; MORTALITY; NON INVASIVE MEASUREMENT; PROGNOSIS; RENOVASCULAR DISEASE; RISK ASSESSMENT;

AGED; ARTERIOSCLEROSIS; BIOLOGICAL MARKERS; FEMALE; HOMOCYSTEINE; HUMANS; HYPERHOMOCYSTEINEMIA; MALE; MIDDLE AGED; PERIPHERAL VASCULAR DISEASES; PROSPECTIVE STUDIES;

EID: 3042523380     PISSN: 03929590     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Taylor LM Jr, Moneta GL, Sexton GL, Schuff RA, Porter JM and The Homocysteine and Progression of Atherosclerosis Study Investigators. Prospective blinded study of the relationship between plasma homocysteine and progression of symptomatic peripheral arterial disease. J Vasc Surg 1999;29:8-21.
2. Nygård O, Nordrehaug JE, Refsum H, Ueland PM, Farstad M, Vollset ST. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997;337:230-7.
3. Ford ES, Smith SJ, Stroup DF, Steinberg KK, Mueller PW, Thacker SB. Homocyst(e)ine and cardiovascular disease: a systematic review of the evidence with special emphasis on case-control studies and nested case-control studies. Int J Epidemiol 2002;31:59-70.
4. Homocysteine Studies Collaboration. Homocysteine and risk of ischemic heart disease and stroke: a meta-analysis. JAMA 2002;288:2015-22.
5. Hansrani M, Stansby G. Homocysteine lowering interventions for peripheral arterial disease and bypass grafts. Cochrane Database Syst Rev 2002;3:CD003285.
6. Malinow MR, Kang SS, Taylor LM, Wong PWK, Coull B, Inahara T et al. Prevalence of hyperhomocyst(e)inemia in patients with peripheral arterial occlusive disease. Circulation 1989;79:1180-8.
7. Rassoul F, Richter V, Janke C, Purschwitz K, Klötzer B, Geisel J et al. Plasma homocysteine and lipoprotein profile in patients with peripheral arterial occlusive disease. Angiology 2000;51:189-96.
8. Cheng SW, Ting AC, Wong J. Fasting total plasma homocysteine and atherosclerotic peripheral vascular disease. Ann Vasc Surg 1997;11:217-23.
9. Taylor LM Jr, DeFrang RD, Harris EJ Jr, Porter JM. The association of elevated plasma homocyst(e)ine with progression of symptomatic peripheral arterial disease. J Vasc Surg 1991;13:128-36.
10. Malinow MR. Homocyst(e)ine and arterial occlusive disease. J Intern Med 1994;236:603-17.
11. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B et al. Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 1991;324: 1149-55.
12. Hoogeveen EK, Kostense PJ, Jakobs C, Rauwerda JA, Dekker JM, Nijpels G et al. Hyperhomocysteinaemia is not associated with isolated crural arterial occlusive disease: The Hoorn Study. J Intern Med 2000;247:442-8.
13. Criqui MH, Denenberg JO. The generalized nature of atherosclerosis: how peripheral arterial disease may predict adverse events from coronary artery disease. Vasc Med 1998;3:241-5.
14. Criqui MH, Langer RD, Fronek A, Feigelson HS. Coronary disease and stroke in patients with large-vessel peripheral arterial disease. Drugs 1991;42:16-21.
15. Taute B-M, Feller S, Hänsgen K, Podhaisky H. Carotid atherosclerosis in patients with peripheral arterial disease. Perfusion 2002;15:183-8.
16. Kang SS, Wong PWK, Malinow MR. Hyperhomocyst(e)inemia as a risk factor for occlusive vascular disease. Annu Rev Nutr 1992;12:279-98.
17. Graham IM, Daly LE, Refsum HM, Robinson K, Brattstrom LE, Ueland PM et al. Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project. JAMA 1997;277:1775-81.
18. Spence JD, Barnett PA, Bulman DE, Hegele RA. An approach to ascertain probands with a non-traditional risk factor for carotid atherosclerosis. Atherosclerosis 1999;144:429-34.
19. Blum A, Lupovitch S, Khazim K, Peleg A, Gumanovsky M, Yeganeh S et al. Homocysteine levels in patients with risk factors for atherosclerosis. Clin Cardiol 2001;24: 463-6.
20. Mueller T, Furtmueller B, Aigelsdorfer J, Luft C, Poelz W, Haltmayer M. Total serum homocysteine: a predictor of extracranial carotid artery stenosis in male patients with symptomatic peripheral arterial disease. Vasc Med 2001;6:163-7.
21. Selhub J, Jacques PF, Bostom AG, D'Agostino RB, Wilson PWF, Belanger AJ et al. Association between plasma homocysteine concentrations and extracranial carotid-artery stenosis. N Engl J Med 1995;332:286-91.
22. Nygård O, Refsum H, Ueland PM, Vollset SE. Major lifestyle determinants of plasma total homocysteine distribution: the Hordaland Homocysteine Study. Am J Clin Nutr 1998;67:263-70.
23. Araki A, Sako Y, Fukushima Y, Matsumoto M, Asada T, Kita T. Plasma sulfhydryl-containing amino acids in patients with cerebral infarction and in hypertensive subjects. Atherosclerosis 1989;79:139-46.
24. Chico A, Perez A, Cordoba A, Arcelus R, Carreras G, de Leiva A et al. Plasma homocysteine is related to albumin excretion rate in patients with diabetes mellitus: a new link between diabetic nephropathy and cardiovascular disease? Diabetologia 1998;41:684-93.
25. Wouters MG, Moorrees MT, van der Mooren MJ, Blom HJ, Boers GH, Schellekens LA et al. Plasma homocysteine and menopausal status. Eur J Clin Invest 1995;25: 801-5.
26. Jacques PF, Rosenberg IH, Roger G, Selhub J, Bowman BA, Gunter EW et al. Serum total homocysteine concentrations in adolescent and adult americans: results from the third National Health and Nutrition Examination Survey. Am J Clin Nutr 1999;69:482-98.
27. Loncar R, Hrboka V, Tabakovic-Loncar V, Ostojic Z, Deussen A. Screening of plasma homocysteine in peripheral arterial disease. Ann Med 2001;33:48-54.